FDNA to Launch Online "Unknown Forum" for Undiagnosed and Challenging Cases at ACMG 2015

NEW YORK, March 12, 2015 /PRNewswire/ --

FDNA, the pioneer in computer-aided dysmorphology analysis, has announced today the launch of an online forum for the genetics expert community  dedicated to the discussion and review of undiagnosed and challenging cases. The company will unveil the online forum in a scheduled theater presentation at the Annual Clinical Genetics Meeting ACMG 2015 in Salt Lake City, UT on March 26th, 2015 at 11:40 am.

Face2Gene facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. One of the unmet needs raised by Face2Gene users worldwide is the need to consult with their peers in the genetics community about certain cases. Some of the cases they encounter have genetic syndromes that are so rare, that only the cumulative knowledge and experience of the larger geneticist community can lead to a diagnosis.

"We are excited to provide this experts-only platform as yet another innovative and free service for the benefit of the genetics expert community," said Mr. Dekel Gelbman, FDNA's Chief Executive Officer. "This novel and innovative solution leverages the accumulated knowledge of Face2Gene's user community to amplify the scientific and clinical value of our technology for the benefit of the entire genetics expert community and, ultimately, benefits the patients and their families," continued Gelbman.

The online Unknown Forum is available for all registered Face2Gene users. FDNA's Expert Review Panel will review the unknown and challenging cases submitted by users. This forum is fully secure and HIPAA compliant, following the most stringent privacy policies, through which clinicians and researchers may benefit from the cumulative experience and knowledge shared by colleagues worldwide.

About FDNA 

FDNA's mission is to save lives and improve the quality of life of patients with rare or difficult-to-diagnose genetic syndromes. FDNA has developed the proprietary Facial Dysmorphology Novel Analysis (FDNA®) technology. This cutting-edge technology facilitates the detection of facial dysmorphic features and recognizable patterns of human malformations from facial photos. For more information: http://www.FDNA.com

Media contact: 
FDNA Inc. 
Yaron Front, 
V.P. Marketing 

[email protected]
+1-347-305-0076

SOURCE FDNA Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED